#InCaseYouMissedIt: Soren Mogelsvang, President & CEO, recently provided 5 reasons why you should pay attention to Exxel in 2025 at the on-demand #VirtualInvestor conference. Watch it here: https://lnkd.in/ewwYzaAh #ChronicCough #HyperactiveBladder #Migraine
Exxel Pharma
Pharmaceutical Manufacturing
Aurora, Colorado 192 followers
Advancing Breakthrough Therapeutics to Transform the Treatment of Neuronal Hypersensitivity Disorders.
About us
Exxel Pharma is a privately held company focused on developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The Company’s lead program, EX937, is a first-in-class, proprietary small molecule being developed for refractory chronic cough, a large underserved market with no current FDA-approved therapies, that affects approximately 10% of the global population. Leveraging a differentiated approach by inhibiting the FAAH enzyme, EX937 has demonstrated efficacy and favorable safety in its ability to modulate chronic cough in preclinical models. The Company is rapidly advancing the development of EX937 towards a first-in-human Phase 1/1b study. EX937 also has the potential to be utilized across a number of blockbuster indications, including hyperactive bladder, peripheral neuropathic pain and migraine headaches.
- Website
-
http://www.exxelpharma.com
External link for Exxel Pharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Aurora, Colorado
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Neuronal Hypersensitivity Disorder, Chronic Cough, Hyperactive Bladder, Neuropathic Pain, and Migraines
Locations
-
Primary
Get directions
12635 E Montview Blvd
Suite 100
Aurora, Colorado 80045, US
Employees at Exxel Pharma
Updates
-
We are advancing a differentiated approach to chronic cough. Learn more here: https://bit.ly/3ZQ0Qmu #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
-
-
#DidYouKnow: Chronic cough has no FDA-approved treatments & current approaches are falling short. Our team is dedicated to making a difference. Learn more: https://bit.ly/3Mh2Xu4 #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
-
-
Sign up for email alerts to stay updated on our latest news! https://bit.ly/3tSAkNC #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
-
-
Want to learn more about Exxel Pharma? Explore our publications for in-depth insights and groundbreaking advancements. https://bit.ly/3tSFFVa #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
-
-
Exxel Pharma reposted this
On-Demand Now! 🎬 Exxel Pharma joined the #VirtualInvestor Top 5 for '25 event—watch our session here: https://lnkd.in/ewwYzaAh #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
Exxel 5 for '25
https://vimeo.com/
-
Exxel Pharma reposted this
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand. Access it here: https://bit.ly/4aX9uoR Akari Therapeutics, Plc Autonomix Medical American Resources Corporation CNS Pharma enVVeno Medical Exxel Pharma GRI Bio, Inc. Kaida BioPharma Outlook Therapeutics, Inc. Palisade Bio TuHURA Biosciences #AKTX #AMIX #AREC #CNSP #NVNO #GRI #OTLK #PALI #HURA
-
Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference https://bit.ly/4b8s39I #ChronicCough #HyperactiveBladder #NeuropathicPain #Migraine
-
#MeetTheTeam dedicated to making a difference in the lives of those living with conditions such as #ChronicCough. Learn more: https://bit.ly/3S0vbwZ #HyperactiveBladder #NeuropathicPain #Migraine
-
-
#ChronicCough is a persistent and distressing cough lasting longer than 8 weeks in adults, overall reducing quality of life and often leading to disruptions in daily activities, sleep and social interactions. #HyperactiveBladder #NeuropathicPain #Migraine
-